Many GLP-1 receptor agonist medicines are peptide-based drugs engineered for useful duration and delivery. Learn the evidence, approval status, safety questions, and FAQs in this plain-English guide.
AOD-9604 is a modified fragment associated with growth-hormone research and is promoted for fat loss. Learn the evidence, approval status, safety questions, and FAQs in this plain-English guide.
MOTS-c is a mitochondrial-derived peptide studied for possible roles in cellular stress and metabolic regulation. Learn the evidence, approval status, safety questions, and FAQs in this plain-English guide.
Retatrutide is often called a triple agonist because it targets GIP, GLP-1, and glucagon receptor pathways. Learn the evidence, approval status, safety questions, and FAQs in this plain-English guide.
Retatrutide is an investigational molecule designed to activate GIP, GLP-1, and glucagon receptors. Learn the evidence, approval status, safety questions, and FAQs in this plain-English guide.